Alzecure Q1 2024: Strengthening the cash position - Redeye
Redeye returns with a research update on Alzecure following its Q1 report and recent events in the company. We further discuss the company's ongoing rights issue and the strategy ahead.
ANNONS
Redeye returns with a research update on Alzecure following its Q1 report and recent events in the company. We further discuss the company's ongoing rights issue and the strategy ahead.